Cargando…
Cell-Free DNA Methylation Analysis as a Marker of Malignancy in Pleural Fluid
BACKGROUND: Diagnosis of malignant pleural effusion (MPE) is made by cytological examination of pleural fluid or histological examination of pleural tissue from biopsy. Unfortunately, detection of malignancy using cytology has an overall sensitivity of 50%, and is dependent upon tumor load, volume o...
Autores principales: | Bixby, Billie, Vrba, Lukas, Lenka, Jyoti, Oshiro, Marc, Watts, George S., Hughes, Trina., Erickson, Heidi, Chopra, Madhav, Knepler, James L., Knox, Kenneth S, Jarnagin, Lisa, Alalawi, Raed, Kala, Mrinalini, Bernert, Richard, Routh, Joshua, Roe, Denise J., Garland, Linda L., Futscher, Bernard W., Nelson, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602127/ https://www.ncbi.nlm.nih.gov/pubmed/37886511 http://dx.doi.org/10.21203/rs.3.rs-3390107/v1 |
Ejemplares similares
-
DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients
por: Vrba, Lukas, et al.
Publicado: (2019) -
SARS-CoV-2 Rapid Antigen Testing of Symptomatic and Asymptomatic Individuals on the University of Arizona Campus
por: Harris, David T., et al.
Publicado: (2021) -
Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease
por: Vrba, Lukas, et al.
Publicado: (2022) -
Epigenetic silencing of lncRNA
MORT in 16 TCGA cancer types
por: Vrba, Lukas, et al.
Publicado: (2018) -
Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes
por: Vrba, Lukas, et al.
Publicado: (2017)